Customized antibodies can be generated in a mouse, rat, or hamster, to meet any host requirements. Companies are providing wide range of antibodies according to the researcher’s requirements. There are variety of customized antibodies in the market which includes polyclonal and monoclonal antibody, recombinant monoclonal antibody, hybridoma antibody, polyclonal recombinant antibody, and others. Companies are offering complete support services for all types and steps of antibody production from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.
Thermo Fisher Scientific Inc. and Abcam — Notable Market Players in Custom Antibody Market
Leading players operating in the custom antibody market adopt various growth strategies, such as product launches, approvals, partnerships, and business planning. These strategies help them expand their business in the global market. As a result, the market majorly consists of the players such as Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Merck KGaA, ABCAM, GenScript, Rockland Immunochemicals, ProMab, BioLegend Inc, Agilent Technologies Inc, and Cell Signaling Technology Inc are among the leading companies operating in the custom antibody market.
Companies such as Thermo Fisher Scientific Inc, Abcam, BioLegend Inc, Bio-Rad Laboratories Inc, and GenScript have been implementing various strategies that have propelled the company’s growth, which, in turn have brought multiple changes in the custom antibody market.
A few growth strategies done by the players operating in the custom antibody market are listed below:
| Month & Year | Description |
| May-2021 | Bio-Rad Laboratories Inc. has received EUA approval from US FDA for its SARS-CoV-2 Total Ab test, which is a blood-based assay to identify all the antibodies that are developed by the human body in response to the novel coronavirus SARS-CoV-2. |
| Apr-2021 | Thermo Fisher Scientific Inc. the world leader in serving science, acquired PPD, Inc. a leading global provider of clinical research services to the pharma and biotech industry. |
| May-2020 | Thermo Fisher Scientific has entered into collaboration with WuXi Diagnostics and the Mayo Clinic to develop ELISA test for detection of IgM and IgG antibodies to the novel coronavirus. |
| Nov-2019 | Abcam plc, a global innovator in life science reagents and tools, is today pleased to announce a strategic partnership with BrickBio, experts in site-specific protein modification and a Tiger Gene portfolio company, covering the use of BrickBio’s proprietary platform for introducing conjugation-ready sites into antibodies and other proteins in both mammalian and bacterial expression systems. |
| Nov-2018 | BioLegend, a world-class antibody provider, announced today a new partnership with VIB, a leading life science research institute in Flanders (Belgium), to evaluate and implement the TotalSeqTM antibodies for next-generation multi-omics by the combining single cell transcriptomics with single cell proteomics profiling. |
